Cargando…
Prolonged thrombocytopenia after CAR T-cell therapy: the role of thrombopoietin receptor agonists
Autores principales: | Drillet, Gaëlle, Lhomme, Faustine, De Guibert, Sophie, Manson, Guillaume, Houot, Roch |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979763/ https://www.ncbi.nlm.nih.gov/pubmed/35930692 http://dx.doi.org/10.1182/bloodadvances.2022008066 |
Ejemplares similares
-
Acute leucoencephalomyelopathy and quadriparesis after CAR T-cell therapy
por: Nair, Ranjit, et al.
Publicado: (2020) -
Role of Thrombopoietin Receptor Agonists in Inherited Thrombocytopenia
por: Bastida, José María, et al.
Publicado: (2021) -
Use of Thrombopoietin Receptor Agonists in Childhood Immune Thrombocytopenia
por: Garzon, Angelica Maria, et al.
Publicado: (2015) -
Optimal use of thrombopoietin receptor agonists in immune thrombocytopenia
por: Al-Samkari, Hanny, et al.
Publicado: (2019) -
Thrombocytopenia and Procedural Prophylaxis in the Era of Thrombopoietin Receptor Agonists
por: Nilles, Kathy M., et al.
Publicado: (2019)